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Abstract
Background: Although several cross-sectional and intervention studies showed that sodium intake or excretion
was associated with blood pressure levels, no prospective study has examined the long-term association between
sodium excretion in spot urine and blood pressure changes.
Methods: We conducted a prospective study of 889 normotensive subjects (295 men and 594 women, mean age
57.3 years) who underwent the baseline survey including spot urine test in 2005 and the follow-up survey in
2009 to 2011 (mean follow-up period: 5.8 years). We examined the association between sodium concentration in
spot urine, a validated index of sodium excretion occurring over 24-h, and blood pressure changes between baseline
and follow-up survey in all, non-overweight (body mass index(BMI) ≤ 25 kg/m2) and overweight normotensives.
Results: For all subjects, sodium concentrations in spot urine were not associated with either systolic or diastolic blood
pressure changes. When stratified by BMI at baseline survey, sodium concentrations were positively associated with
systolic blood pressure changes in non-overweight subjects, but not in overweight subjects. After adjustment for age,
sex, BMI, alcohol intake status, current smoking and estimated glomerular filtration rate, the multivariable-adjusted
mean values of the systolic blood pressure change among non-overweight subjects was +7.3 mmHg in the highest
quartiles of sodium concentrations, while it was +3.9 mmHg in the lowest quartile (P for difference = 0.021, P for
trend = 0.040). After further adjustment of baseline blood pressure levels, the association was slightly weakened;
the multivariable-adjusted mean values of the systolic blood pressure changes were +7.0 mmHg and +4.2 mmHg
(P for difference = 0.047, P for trend = 0.071).
Conclusions: High sodium concentrations in spot urine were associated with subsequent systolic blood pressure
increases among non-overweight normotensive individuals. (272 words)
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Background
The relationship between sodium intake and blood pres-
sure has been investigated since the 1900s and the asso-
ciations between sodium intake/excretion and blood
pressure levels have been studied mainly by using cross-
sectional designs [1–6]. Furthermore, a randomized con-
trolled trial of individuals whose systolic blood pressure
of 120 to 159 mmHg and/or diastolic blood pressure of
80 to 95 mmHg showed that the reduction in sodium in-
take from 150 to 50 mmol/day (8.8 to 2.9 g/day salt)
lowered both systolic and diastolic blood pressure levels
by 4.8 mmHg and 2.6 mmHg, respectively over the 90-
day intervention [7]. A clinical experimental study of 14
normotensive men showed that an extreme sodium in-
take, 800 mmol/day (46.8 g/day salt intake) at three days
increased systolic and diastolic blood pressure levels by
8 mmHg and 7 mmHg, respectively [8]. However, no
prospective studies have evaluated the long-term effects
of high sodium intake or excretion on subsequent blood
pressure changes in general populations. For the primary
and secondary prevention of hypertension, the investiga-
tion of relationship between sodium intake or excretion
with subsequent blood pressure changes among general
populations is warranted.
The prevalence of hypertension has been reported to
be similar between the Japanese and American popula-
tions. According to national surveys, the prevalence of
hypertension among 40 to 64-year-old Japanese men
and women was 42 % [9], while the prevalence among
45 to 64-year-old US men and women was 41 % [10].
As for subjects aged 65 years or more, the prevalence
was 69 % among Japanese and 70 % among Americans.
However, the causes or related factors of hypertension
may be different in Japanese and Americans. Compared
with Americans, Japanese have the lower prevalence of
obesity but consume higher amounts of sodium [9, 11, 12].
Mean values of body mass index (BMI) among Japanese
adults were found to be 23.4 kg/m2 in men and
22.4 kg/m2 in women [9], while they were 27.8 kg/m2
in US men and 28.1 kg/m2 in US women [11]. Accord-
ing to the Japan National Nutrition Survey, mean so-
dium intake was 4,488 mg/day (11.4 g/day salt) in men
and 3,858 mg/day (9.8 g/day salt) in women [9], while
in the United States, mean sodium intake was 3,877 mg/
day (9.9 g/day salt) in men and 2,896 mg/day (7.4 g/day
salt) in women [12]. Therefore, from a public health point
of view, it is important to evaluate an effect of sodium on
blood pressure levels in Japanese populations, whose
mean sodium intake is high.
A “gold standard” to evaluate sodium intake or excre-
tion would be a urine sample collection repeated every
24 h, but it is not easy to conduct such an assay for gen-
eral populations. Several studies have shown that spot
urine is also a practical and useful method to evaluate
sodium excretion [13–15]. Using spot urine, we sought
to test the hypothesis that urinary sodium excretion is
positively associated with subsequent blood pressure in-
creases in a prospective study of a Japanese population.
Fig. 1 Study subjects
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Methods
Population and subjects
The subjects were residents of Kyowa, a rural district of
Chikusei City, Ibaraki Prefecture, Japan. The population
in the area was 16,778 (8,270 men and 8,508 women),
determined by census in 2005. The Kyowa community is
a community-based part of the Circulatory Risk in the
Community Study (CIRCS) [16], and annual cardiovas-
cular risk surveys have been conducted between mid-
November and mid-December since 1981.
There were 2,729 participants (1,037 men and 1,692
women) aged 40 to 75 years old in the 2005 baseline
cardiovascular risk survey. We excluded 35 subjects be-
cause they refused to take urinalysis (n = 8); they re-
fused to take blood samples (n = 2); they had high-
serum creatinine concentrations (≥ 1.4 mg/dl for men
and ≥ 1.2 mg/dl for women) or had a history of renal
disease (n = 18); extremely high sodium to creatinine
ratio in spot urine (≥ 15) (n = 4) or non-validated height
due to scoliosis (n = 3). Of the remaining 2,694 subjects,
1,516 subjects were normotensive and 1,178 subjects
were hypertensive (systolic blood pressure of ≥ 140 mm
Hg and/or diastolic blood pressure of ≥ 90 mm Hg and/
or under antihypertensive medication). Of the normo-
tensive 1,516 subjects, 971 subjects (64.1 %) partici-
pated in follow-up cardiovascular risk surveys in 2009
to 2011. We excluded 71 subjects who initiated antihy-
pertensive medication at follow-up surveys. We also ex-
cluded 11 subjects because they measured their blood
pressure only once (but not twice) at follow-up surveys.
Finally, we used the data from 889 normotensive sub-
jects (295 men and 594 women, mean age 57.3 years) for
the analyses (Fig. 1). If the subjects had participated in
cardiovascular risk surveys twice or more between 2009
and 2011, we used their most recently acquired data for
the analyses: The numbers of subjects we used were 71
in 2009, 91 in 2010 and 727 in 2011.
Ethics, consent and permissions
This study was approved by the Ethics Committee in
University of Tsukuba (12–4, 66–2), Osaka University
(13482, 14285) and Dokkyo Medical University (dmu-
25004), and institutional review boards of the Osaka
Center for Cancer and Cardiovascular Diseases Preven-
tion (26-rinri-1). According to the Japanese ethics guide-
lines, we provided the ethical information on our study
at the survey sites and opt out opportunities.
Population surveys
Individuals who participated in the survey collected
their urine in 10-ml plastic urine containers. Concen-
trations of urine components such as sodium, potas-
sium, urea nitrogen, and creatinine were analyzed using
an electrolyte analyzer (Hitachi/Roche; Hitachi, Tokyo,
Japan) (Additional file 1). Quality control was under-
gone three times per day by using normal and abnor-
mal reagent (Consela “Nissui”, Nissui pharmaceutical
Co., Tokyo, Japan).
In the baseline survey, arterial systolic blood pressure
and the fifth-phase of Korotkoff sounds diastolic blood
pressure were measured by well-trained observers using
standard mercury sphygmomanometers on the right
arm. Observers used large cuff when a subject was large
arm circumference. All participants had their blood
pressure levels measured twice. In the follow-up survey,
participants had their blood pressure levels measured by
automated sphygmomanometers (TM-2655P; A&D
Company Ltd. Tokyo, Japan) on the right arm twice. Ac-
cording to the validation study of TM-2655 series, the
TM-2655 device achieved British Hypertension Society
grade A for systolic and A for diastolic blood pressures,
and the proportions of values agreeing to within
5 mmHg were 72.5 % for systolic blood pressure and
78.8 % for diastolic blood pressure [17]. In addition, we
added 1.0 mmHg for the value of systolic blood pressure
and 0.9 mmHg for the value of diastolic blood pressure,
because the validation study of TM-2655 device showed
that the average difference between mercury sphygmo-
manometer and TM-2655 reading for systolic blood
pressure level was −1.0 ± 5.2 mmHg and that for dia-
stolic blood pressure level was −0.9 ± 4.7 mmHg [17].
The average value of first and second blood pressure
measurement were used for the analyses. We calculated
blood pressure changes by subtracting blood pressure
values in the baseline survey from the values in the
follow-up study.
Validation study
The validity of measurement of the components in spot
urine was checked in a subsample of 225 subjects (85
men and 140 women) who underwent 24-h urine collec-
tion in 2005 [18]. The concordance rate between the
quartiles of urinary sodium concentration in spot urine
and of 24-h urinary sodium excretion was 40.0 % for
men, 32.1 % for women and 35.1 % for total subjects.
The sodium to creatinine ratio in urine has frequently
been used as a marker of sodium excretion during 24-h
urine collections [13–15]. In the present study, however,
we found a stronger association between sodium con-
centrations in spot urine and in urine collected over 24-h
than between the sodium to creatinine ratio in urine;
the Spearman correlation coefficient between sodium
concentrations in spot urine and urinary sodium excre-
tion in samples collected over 24-hours was
0.39 (P<0.01; sodium excretion (g/day)= 0.032 x sodium
concentration (mmol/l) -2.278 (women) + 9.130) , while
it was 0.16 between the sodium to creatinine ratio in
spot urine, and 24-h urinary sodium excretion.
Umesawa et al. BMC Cardiovascular Disorders  (2016) 16:55 Page 3 of 9
Therefore, we used the sodium concentrations in spot
urine as an index of the level of sodium excretion. As
for potassium and urea nitrogen, the Spearman correl-
ation coefficients between their concentrations in spot
urine and their levels of urinary excretion over 24-h
were 0.01 and 0.31, respectively. The Spearman correl-
ation coefficient between the potassium to creatinine
ratio in spot urine and 24-h urinary potassium excre-
tions was 0.20. That between of the urea nitrogen to
creatinine ratio in spot urine and 24-h urinary urea ni-
trogen excretions was 0.11.
We calculated estimated glomerular filtration rate
(eGFR) (ml/min/1.73 m2) according to the following for-
mula, established by the working group of the Japanese
Chronic Kidney Disease Initiative: eGFR (ml/min/
1.73 m2) = 1.94 x (serum creatinine)-1.094 x (age)-0.287 for
men and 1.94 x (serum creatinine)-1.094 x (age)-0.287 x
0.739 for women [19].
Statistical analysis
The analysis was performed for blood pressure changes
according to quartiles of sodium concentrations in spot
urine. We present the combined data for men and
women, because we tested sex interaction for the each
analysis and found no significant interactions (P for
interaction = 0.96 for systolic blood pressure and P for
interaction = 0.36 for diastolic blood pressure). We per-
formed the stratified analysis by the presence or ab-
sence of overweight (BMI ≥ 25 kg/m2) because sodium
sensitivity can be enhanced in the overweight subjects
[20, 21].
Age- and sex-adjusted means and proportions of con-
founding variables were calculated and tested by analysis
of covariance. We used the following formula to calcu-
late the HbA1c value based on the JDS value and the
National Glycohemoglobin Standardization Program
(NGSP) value: HbA1c (NGSP) = 1.02 × HbA1c(JDS) +
0.25 % [22]. We defined diabetes when HbA1c level
was ≥ 6.5 % and/or medicated for diabetes mellitus.
Age- and sex-adjusted, and multivariable-adjusted mean
values of changes in systolic and diastolic blood pressure
were also calculated and tested by the analysis of covari-
ance. The mean values of blood pressure changes associ-
ated with changes in one standard deviation (1-SD)
increment of sodium concentrations were calculated using
the multivariate linear regression analysis.
The confounding variables for adjustment included
age (years), sex, BMI (kg/m2), drinking status (never, ex-
drinkers, current drinkers of ethanol at 1 to 22 g/day
and ≥ 23 g/day), current smoking (yes or no) and eGFR
(ml/min/1.73 m2). We also used the baseline value of
systolic or diastolic blood pressure level as confounding
variable.
We used SAS version 9.3 software (SAS Institute,
Cary, NC) for all analyses. P values < 0.05 (two-tailed)
were considered statistically significant.
Results
The distribution of sodium concentration in spot urine
among all subjects is illustrated in Additional file 1:
Figure S1. Sodium concentrations ranged from 19 to 307
mmol/L with the peak at 101 mmol/L. The baseline
characteristics according to quartiles of sodium concen-
trations in spot urine are shown in Table 1. For all sub-
jects and non-overweight subjects, compared with the
lowest quartile of sodium concentrations, the highest
quartile had higher means of BMI, but not proportions
of diabetes mellitus. For non-overweight subjects, com-
pared with the lowest quartile of sodium concentrations,
the highest quartile had higher means of eGFR. For
overweight subjects, compared with the lowest quartile
of sodium concentrations, the highest quartile had lower
proportion of current smoker, and the secondary highest
quartiles had higher mean diastolic blood pressure.
Mean values in systolic and diastolic blood pressures at
baseline and follow-up surveys among all subjects are il-
lustrated in Additional file 2: Figure S2. Mean values of
blood pressure increased by 5.1 mmHg for systolic and by
1.0 mmHg for diastolic during the follow-up. The change
in diastolic blood pressure was larger in overweight than
in non-overweight subjects, and the change in systolic
blood pressure was larger in ages of 60-74 than in ages of
40-59. There was no sex difference in the changes if
systolic and diastolic blood pressures (Additional file 3:
Figure S3). Table 2 shows age- and sex-adjusted, and
multivariable-adjusted blood pressure changes according
to quartiles and 1-SD (53 to 55 mmol/l) increment of
sodium concentrations in spot urine among all, non-
overweight and overweight subjects. For all subjects, after
adjustment for age, sex, BMI, drinking status, current
smoking and eGFR, the mean value of systolic blood
pressure changes associated with 1-SD increment of
sodium concentrations was +0.9 mmHg (P = 0.060). The
corresponding mean value was +6.8 mmHg in the highest
quartile of sodium concentrations while it was +4.5 mmHg
in the lowest quartile (P for difference = 0.078). For
non-overweight subjects, the multivariable-adjusted mean
of systolic blood pressure changes associated with 1-SD
increment of sodium concentrations was +1.1 mmHg
(P = 0.040). The corresponding mean value was +7.3 mmHg
in the highest quartile of sodium concentrations, while it
was +3.9 mmHg in the lowest quartile (P for difference =
0.021). After further adjustment for baseline blood pres-
sure levels, these association were weakened slightly; the
multivariable-adjusted mean of systolic blood pressure
changes associated with 1-SD increment of sodium concen-
trations was +0.9 mmHg (P = 0.071). The corresponding
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Table 1 Age- and sex-adjusted characteristics according to quartiles of sodium concentrations in spot urine
Sodium concentration quartiles in spot urine
1 (low) 2 3 4 (high)
All subjects (n = 889)
Number 220 225 220 224
Median sodium concentration (mmol/l) 66 107 145 193
Range of sodium concentration (mmol/l) 19–94 82–137 119–176 163–307
Age (years) 57.7 56.9 58.3 56.3
Range of age (years) 40–75 40–75 40–75 40–75
Women (%) 67 67 67 67
Body mass index (kg/m2) 22.4 ± 0.2a 22.6 ± 0.2 22.9 ± 0.2 23.2 ± 0.2**
Current drinker (%) 27 30 28 33
Current smoker (%) 13 14 13 13
Systolic blood pressure levels (mmHg) 118.4 ± 0.8 117.8 ± 0.8 118.7 ± 0.8 118.2 ± 0.8
Diastolic blood pressure levels (mmHg) 72.7 ± 0.5 72.4 ± 0.5 74.0 ± 0.5 73.0 ± 0.5
Diabetes mellitus (%) 8 6 3** 5
eGFR(ml/min/1.73 m2) 83.2 ± 1.1 83.7 ± 1.1 83.2 ± 1.1 85.5 ± 1.1
Non-overweight subjects (BMI < 25) (n = 700)
Number 175 174 176 175
Median sodium concentration (mmol/l) 65 104 144 190
Range of sodium concentration (mmol/l) 19–91 81–133 118–169 161–304
Age (years) 57.6 56.7 58.0 56.3
Range of age (years) 40–75 40–75 40–75 40–75
Women (%) 68 68 68 68
Body mass index (kg/m2) 21.5 ± 0.1 21.7 ± 0.1 21.7 ± 0.1 22.1 ± 0.1**
Current drinker (%) 25 31 32 32
Current smoker (%) 13 14 11 15
Systolic blood pressure levels (mmHg) 117.8 ± 0.9 117.0 ± 0.9 117.6 ± 0.9 117.0 ± 0.9
Diastolic blood pressure levels (mmHg) 72.3 ± 0.6 72.2 ± 0.6 73.1 ± 0.6 72.1 ± 0.6
Diabetes mellitus (%) 7 5 4 4
eGFR(ml/min/1.73 m2) 82.9 ± 1.2 84.7 ± 1.2 84.2 ± 1.2 86.3 ± 1.2*
Overweight subjects (BMI≥ 25) (n = 189)
Number 46 48 48 47
Median sodium concentration (mmol/l) 71 117 154 203
Range of sodium concentration (mmol/l) 20–112 90–149 127–185 170–307
Age (years) 57.6 59.6 58.2 55.8
Range of age (years) 40–70 41–73 43–74 40–74
Women (%) 63 63 60 64
Body mass index (kg/m2) 26.9 ± 0.2 26.5 ± 0.2 26.5 ± 0.2 26.9 ± 0.2
Current drinker (%) 28 20 26 38
Current smoker (%) 20 9 18 4*
Systolic blood pressure levels (mmHg) 120.5 ± 1.4 121.3 ± 1.4 122.8 ± 1.4 122.3 ± 1.4
Diastolic blood pressure levels (mmHg) 72.8 ± 1.1 75.6 ± 1.1 77.1 ± 1.1** 75.3 ± 1.1
Diabetes mellitus (%) 15 4* 1** 10
eGFR(ml/min/1.73 m2) 83.8 ± 2.5 79.2 ± 2.4 80.2 ± 2.4 83.1 ± 2.5
Difference from the lowest quartile: *P < 0.05, **P < 0.01
aMean ± SE (all such values)
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mean value was +7.0 mmHg in the highest quartile of
sodium concentrations, while it was +4.2 mmHg in the
lowest quartile (P for difference = 0.047). For overweight
subjects, no significant associations were observed between
sodium concentrations and systolic blood pressure changes.
For all categories, no significant changes were observed for
diastolic blood pressure. We tested the interactions of
sodium concentrations with body mass index, and found
no significant interaction between them.
Additionally, we examined the association between
sodium/creatinine ratio and blood pressure changes; how-
ever, the association was not statistically significant. The
multivariable-adjusted means of systolic and diastolic
blood pressure changes associated with 1-SD increment of
sodium/creatinine ratio were −0.6 mmHg (P = 0.187)
and +0.1 mmHg (P = 0.728) for all subjects, respectively.
We also examined the association between sodium/
potassium ratio and blood pressure changes; however,
Table 2 Multivariable-adjusted blood pressure changes in normotensives according to quartiles and 1-SD increment of sodium
concentrations
Sodium concentration quartiles in spot urine
1(low) 2 3 4(high) 1-SDa
All subjects (n = 889)
Number 220 225 220 224 54 mmol/l
Changes in systolic blood pressure level (mmHg)
Age- and sex-adjusted 4.3 4.1 5.2 6.9 1.0*
Multivariable-adjustedb 4.5 4.2 5.1 6.8 0.9
Multivariable-adjustedc 4.6 4.1 5.2 6.6 0.8
Changes in diastolic blood pressure level (mmHg)
Age- and sex-adjusted 0.9 0.6 0.3 2.1 0.4
Multivariable-adjustedb 1.0 0.7 0.3 2.1 0.4
Multivariable-adjustedd 0.9 0.4 0.7 1.9 0.4
Non-overweight subjects (BMI < 25) (n = 700)
Number 175 174 176 175 53 mmol/l
Changes in systolic blood pressure level (mmHg)
Age- and sex-adjusted 3.8 4.2 4.2 7.3* 1.1*
Multivariable-adjustedb 3.9 4.3 4.1 7.3* 1.1*
Multivariable-adjustedc 4.2 4.1 4.2 7.0* 0.9
Changes in diastolic blood pressure level (mmHg)
Age- and sex-adjusted 0.8 0.5 0.1 2.3 0.4
Multivariable-adjustedb 0.8 0.5 0.0 2.3 0.4
Multivariable-adjustedd 0.8 0.4 0.3 2.0 0.3
Overweight subjects (BMI≥ 25) (n = 189)
Number 46 48 48 47 55 mmol/l
Changes in systolic blood pressure level (mmHg)
Age- and sex-adjusted 5.9 5.0 7.1 6.3 0.2
Multivariable-adjustedb 5.6 5.0 7.0 6.7 0.4
Multivariable-adjustedc 5.3 5.0 7.3 6.8 0.6
Changes in diastolic blood pressure level (mmHg)
Age- and sex-adjusted 2.5 −0.3 0.5 2.9 0.6
Multivariable-adjustedb 2.4 −0.4 0.6 3.0 0.7
Multivariable-adjustedd 1.4 −0.1 1.4 2.9 0.9
Difference from the lowest quartile: *P < 0.05
a1-SD corresponed to 54 mol/L for all subjects, 53 mol/L for non-overweight subjects and 55 mmol/L for overweight subjects
bAdjusted for age (years), sex, body mass index (kg/m2), drinking status (never, ex-drinkers, current drinkers of ethanol at 1 to 22 g/day and ≥23 g/day), current
smoking (yes or no) and baseline eGFR value (ml/min/1.73 m2)
cAdjustment further for baseline systolic blood pressure levels (mmHg)
dAdjustment further for baseline diastolic blood pressure levels (mmHg)
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the association was null. The multivariable-adjusted
means of systolic and diastolic blood pressure changes
associated with 1-SD increment of sodium/potassium
ratio were −0.3 mmHg (P = 0.515) and 0.0 mmHg (P =
0.990) for all subjects, respectively. Those associations
did not differ materially between non-overweight and
overweight subjects.
Discussion
The main finding of this study was that sodium concen-
trations in spot urine were positively associated with
subsequent systolic blood pressure changes in non-
overweight normotensives.
A cross-sectional study in the United Kingdom, con-
sisting of 23,104 men and women aged 45 to 79 years,
showed positive associations between the ratio of urinary
sodium to creatinine in spot urine samples and systolic
and diastolic blood pressure levels in both men and
women [2]. A cross-sectional study of 1,120 Japanese
men and women aged 30-years or over showed a posi-
tive association between the ratio of urinary sodium to
creatinine, and systolic and diastolic blood pressure
levels in women, but not in men [3]. A cross-sectional
study of 7,441 Japanese women aged 40- to 69-years
showed a positive association between estimated 24-h
sodium excretion and systolic and diastolic blood
pressure level [4]. In the present study, positive associ-
ations between sodium concentrations in spot urine
and subsequent increases in systolic blood pressure
levels were observed for men and women without sex
interaction.
Sodium concentrations in spot urine were significantly
associated with systolic blood pressure changes and but
not with diastolic blood pressure changes in the present
study. According to a previous interventional study, the
reduction of dietary sodium intake (−44 mmol/day) was
significantly associated with both systolic and diastolic
blood pressure levels (−1.7 mmHg and −0.9 mmHg, re-
spectively). The association was stronger in systolic blood
pressure levels than in diastolic blood pressure levels [23].
Several mechanisms may be involved in the associ-
ation between sodium excretion and increments in
blood pressure levels. First, human kidneys cannot ex-
crete excess sodium completely and thus accumulate
water to decrease sodium concentrations in extracellu-
lar fluid [24]. This leads to an increase in extracellular
fluid and raises pressure in vessels. Second, the excess
sodium in extracellular fluid affects the physiology of
vascular smooth muscle cells [24]. Increased extracellu-
lar sodium inhibits sodium-potassium pumps in arterial
vascular smooth muscle cells and raises intracellular
sodium concentrations. Excessive intracellular sodium
concentrations stimulate sodium-calcium pumps and
raise intracellular calcium concentrations, which
stimulate actin-myosin interaction leading to vascular
contraction. Third, the renal excretion of excess sodium
in the circulation needed blood pressure increment as
the Guyton auto-regulation theory [25]. Fourth, excess
sodium intake may damage the renal function, leading
to a blood pressure increase. In the present study, for
total subjects, the multivariable-adjusted mean value of
eGFR in the follow-up survey was significantly lower in
the highest quartile of sodium concentrations in urine,
compared with the lowest. The multivariable-adjusted
mean eGFR was 74.9 ml/min/1.73 m2 in the highest
quartile, while it was 76.7 ml/min/1.73 m2 in the lowest
quartile (P for difference = 0.038).
In the present study, we found the significant associ-
ation between sodium concentrations in spot urine and
blood pressure changes in non-overweight but not over-
weight normotensives. The finding did not corroborate
an implication that overweight or metabolic syndrome
may enhance salt sensitivity [20, 21], making the salt-
blood pressure association stronger. It is possible that
overweight may mask that association because of its
strong effect on blood pressure.
The strength of the present study is that we conducted
a prospective study of a community-based Japanese
population sample. Prospective studies can show certain
causal relationships and more relevant results compared
with cross-sectional studies.
The limitations of the present study warrant discus-
sion. First, the correlation between sodium concentra-
tions in spot urine and urine samples collected was
very moderate. However, any errors concerning the
misclassification were nondifferential and would have
attenuated the association between sodium concentra-
tion and blood pressure changes. Second, we changed
the device of blood pressure measurement from stran-
dard mercury to automated sphygmomanometers in
2009 (the beginning of the follow-up study). However,
the validation study allowed us to adjust the values of
blood pressure between the two devices. Third, the
follow-up rate of the present study was 64 %. However,
there was no significant difference in baseline survey
between subjects who participated in follow-up surveys
and who did not, except for the proportion of current
smoker. Subjects who participated in follow-up surveys
showed the lower proportion of current smoker at
baseline compared with subjects who did not (15 % vs.
21 %, P < 0.001). Because current smoking was not as-
sociated with blood pressure changes, such a selection
bias unlikely affect our results. Fourth, we could not
evaluate the changes of sodium intake between baseline
and follow-up surveys because we did not measure
sodium concentrations in spot urine repeatedly. Fifth, we
have no information about education status, income and
other social factors as potential confounding factors.
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Conclusion
High sodium concentrations in spot urine, an index of
sodium excretion, was positively associated with future
systolic blood pressure changes among non-overweight
normotensive Japanese.
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